All news articles for September 2014

“Work on further reducing production costs will continue post-launch...

Swiss player ready for reduced cost resveratrol launch

By Shane STARLING

10-year-old Swiss biotech firm Evolva has completed the resveratrol manufacturing cost-reduction programme it embarked on for the antioxidant nearly two years ago when it bought defunct Fluxome’s business for €550,000.

Arla will triple whey hydrolysates output by 2016

Arla pours €38m into facility to meet whey demand

By Shane STARLING

Dairy giant Arla's ingredients business is building a new whey processing facility for €38m to meet rising demand for the dairy fraction in infant, sports and clinical nutrition.

Follow us

Products

View more

Webinars